| Literature DB >> 31379923 |
Abstract
DNA transformation of parasitic nematodes enables novel approaches to validating predictions from genomic and transcriptomic studies of these important pathogens. Notably, proof of principle for CRISPR/Cas9 mutagenesis has been achieved in Strongyloides spp., allowing identification of molecules essential to the functions of sensory neurons that mediate behaviors comprising host finding, invasion, and location of predilection sites by parasitic nematodes. Likewise, CRISPR/Cas9 knockout of the developmental regulatory transcription factor Ss-daf-16 has validated its function in regulating morphogenesis of infective third-stage larvae in Strongyloides stercoralis. While encouraging, these studies underscore challenges that remain in achieving straightforward validation of essential intervention targets in parasitic nematodes. Chief among these is the likelihood that knockout of multifunctional regulators like Ss-DAF-16 or its downstream mediator, the nuclear receptor Ss-DAF-12, will produce phenotypes so complex as to defy interpretation and will render affected worms incapable of infecting their hosts, thus preventing establishment of stable mutant lines. Approaches to overcoming these impediments could involve refinements to current CRISPR/Cas9 methods in Strongyloides including regulatable Cas9 expression from integrated transgenes and CRISPR/Cas9 editing to ablate specific functional motifs in regulatory molecules without complete knockout. Another approach would express transgenes encoding regulatory molecules of interest with mutations designed to similarly ablate or degrade specific functional motifs such as the ligand binding domain of Ss-DAF-12 while preserving core functions such as DNA binding. Such mutant transgenes would be expected to exert a dominant interfering effect on their endogenous counterparts. Published reports validate the utility of such dominant-negative approaches in Strongyloides.Entities:
Keywords: CRISPR/Cas9; dominant transgene; mutagenesis; parasitic nematode; transgenesis
Year: 2019 PMID: 31379923 PMCID: PMC6646703 DOI: 10.3389/fgene.2019.00656
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1Strategies for transfer of nucleic acids into parasitic nematodes. (A) Microinjection of plasmid vector constructs into the syncytial gonads (shaded area of distal gonad arm in cartoon) of parental free-living female Strongyloides and Parastrongyloides, with or without transposon-mediated integration. Transiently transformed F1 larvae may be investigated for reporter expression patterns or phenotypes induced by dominant transgenes or CRISPR/Cas9-mediated gene disruption or editing. Lines of parasites with transgenes integrated by the co-injected piggyBac transposon system may be selected and maintained by alternating host and culture passage. (B) Biolistic transfer of reporter DNA constructs into Brugia malayi embryos within adult female worms has enabled definition of basic gene regulatory elements and has identified elements for ecdysteroid signaling in this parasite. Embryos transformed in this manner have thus far been incapable of further development. (C) Chemically mediated vector transfer in B. malayi by co-injection of parental infective third-stage larvae (L3i) into susceptible gerbils. Transgenic adult parasites and transgenic F1 microfilariae result from this procedure. (D) Refinement of chemically mediated transfection involving lipofectant transfer of plasmid vectors with the piggyBac transposon system to parental L3i of B. malayi undergoing the molt to L4 in culture and then inoculated intraperitoneally in to susceptible gerbils. F1 transgenic microfilariae include integrants and may prove amenable to selection of stable lines by mosquito and gerbil passage. (E) Biolistic transfer of DNA and RNA into embryos of Ascaris suum. This approach has enabled studies of RNA processing in these parasites.
Figure 2Strategies for creating dominant interfering transgene constructs to study functions of catalytic, signaling, and gene regulatory proteins. (A). Strategy for dominant interfering transgenes targeting functions of metabolic enzymes and cytoplasmic signaling kinases. Overexpression of mutant construct with intact substrate binding domain and catalytic site disrupted by mutation serves to outcompete endogenous gene product for substrate while yielding no phosphorylated or enzyme metabolized product. (B). Design of dominant interfering transgenes targeting functions of membrane receptor kinases. Ablation of the kinase domain by mutation, an intact ligand binding domain and overexpression combine to out-compete the endogenous receptor kinase for ligand while failing to phosphorylate downstream cytoplasmic signaling elements. (C). Design of dominant interfering transgenes targeting the action of transcription factors. Overexpression of a mutant transgene encoding an intact DNA binding domain, mutations in phosphorylation sites to effect constitutive nuclear localization, and disruption of the transactivating domain serve to outcompete the endogenous transcription factor for genomic response elements while failing to execute gene regulatory function.